Puma Biotechnology, Inc.PBYINASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank71
3Y CAGR+9.2%
5Y CAGR-7.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+9.2%/yr
vs -25.6%/yr prior
5Y CAGR
-7.9%/yr
Recent acceleration
Acceleration
+34.8pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.30 | +95.2% |
| 2024 | 0.66 | -32.2% |
| 2023 | 0.98 | -1.5% |
| 2022 | 1.00 | +42.4% |
| 2021 | 0.70 | -64.4% |
| 2020 | 1.96 | +33.8% |
| 2019 | 1.47 | -54.9% |
| 2018 | 3.25 | -97.5% |
| 2017 | 131.44 | - |
| 2016 | 0.00 | - |